PTEN gene targeting reveals a radiation-induced size checkpoint in human cancer cells

Carolyn Lee1, Jung-Sik Kim, Todd Waldman

  • 1Department of Oncology and Tumor Biology Training Program, Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, Washington, District of Columbia 20057, USA.

Cancer Research
|October 7, 2004
PubMed

Insights

Human cancer cells lacking PTEN cannot arrest cell size after DNA damage, leading to increased radiosensitivity. Restoring size arrest via inhibiting PI3K/mTOR pathways can re-sensitize these cells to radiation.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Molecular Oncology

Background:

  • Human cells typically arrest in G1 and G2 phases after DNA damage.
  • PTEN is a critical tumor suppressor gene involved in cell growth and survival pathways.

Purpose of the Study:

  • To investigate the role of PTEN in DNA damage-induced cell cycle and size arrest.
  • To determine the impact of PTEN loss on radiosensitivity.
  • To explore therapeutic strategies targeting cell size regulation in PTEN-deficient cancers.

Main Methods:

  • Irradiation of human cancer cells with PTEN deletion or mutations.
  • Pharmacological inhibition of phosphoinositol-3-kinase (PI3K) and mTOR.
  • siRNA-mediated depletion of TSC2.
  • Assessment of cell cycle progression, cell size, Akt activation, and radiosensitivity (in vitro and in vivo).

Main Results:

  • PTEN-deficient cells arrest in G1/G2 but not in size after irradiation.
  • Inhibition of PI3K/mTOR restored size arrest in PTEN(-/-) cells.
  • TSC2 depletion attenuated size arrest in PTEN(+/+) cells.
  • Radiation potentiated Akt activation in PTEN(-/-) cells.
  • Loss of PTEN and abrogation of size arrest conferred radiosensitivity.

Conclusions:

  • PTEN regulates a DNA damage-inducible cell size arrest, genetically separable from G1/G2 arrests.
  • Aberrant cell size regulation in PTEN-deficient cancers contributes to radiosensitivity.
  • Targeting cell size regulation may offer therapeutic benefits for PTEN-mutant cancers.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...